The government has procured 33,600 doses of Mpox vaccines to boost the country’s response to the epidemic.
The Minister of Health, Kwabena Mintah Akandoh, who announced this on Saturday, said the move would reinforce ongoing efforts to contain the outbreak and protect public health.
The vaccines will be administered to high-risk groups, particularly in areas where the disease is most prevalent.
Currently, the Western Region has been identified as the epicentre, accounting for 71 per cent of all confirmed cases, though infections have been recorded in 10 out of the 16 regions.
According to the Ghana Health Service (GHS), the country had recorded 346 cases of Mpox as of August 7, 2025.
While no patients are currently on admission, one death has been reported this year.
Health authorities say surveillance has been heightened nationwide to curb further spread of the disease.
They have also urged the public to remain vigilant and adhere to preventive measures, including avoiding close contact with persons showing symptoms such as skin rashes, swollen lymph nodes, fever, headaches and fatigue.
The GHS further advised frequent handwashing with soap under running water, wearing masks, covering lesions of infected persons, and avoiding contact with animals that may carry the virus.
Mpox is a viral disease transmitted mainly through skin-to-skin contact with infected persons, animals or contaminated surfaces.
The World Health Organisation (WHO) declared it a public health emergency of international concern in August 2024.
While global case numbers have decreased since the 2022 peak, mpox remains a public health concern, particularly in endemic areas.
The WHO last year approved several vaccines for Mpox, including MVA-BN, LC16m8, and ACAM2000, as part of the global response to the outbreak.
Several African countries, including DRC, Nigeria, Rwanda, and the Central African Republic, have already begun vaccinating their populations, primarily focusing on adults aged 18 and older.
Other countries such as Kenya, Uganda, Sierra Leone, and Liberia have also received vaccine doses through GAVI’s advance purchase agreement.